Citation Impact
Citing Papers
Genetic deficiency of C4, C2 or C1q and lupus syndromes. Association with anti-Ro (SS-A) antibodies.
1985
Antinuclear Antibodies: Diagnostic Markers for Autoimmune Diseases and Probes for Cell Biology
1989 Standout
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel
2000 Standout
Hydroxychloroquine cardiotoxicity in systemic lupus erythematosus: a report of 2 cases and review of the literature
2004
Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
2020 Standout
Hydroxychloroquine: From Malaria to Autoimmunity
2011 Standout
Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review
2008 Standout
Juvenile idiopathic arthritis
2007 Standout
Effects of stress throughout the lifespan on the brain, behaviour and cognition
2009 Standout
Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis
2004 Standout
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIII. Baseline predictors of vascular events
2004
The Epidemiology of low back pain
2010 Standout
Prevention of VTE in Nonsurgical Patients
2012 Standout
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT)
2006 Standout
Mechanisms involved in the side effects of glucocorticoids
2002 Standout
Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States
1998 Standout
Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis
2000 Standout
The Role of Knee Alignment in Disease Progression and Functional Decline in Knee Osteoarthritis
2001 Standout
SYSTEMIC LUPUS ERYTHEMATOSUS FLARES DURING PREGNANCY
1997
Extrapituitary Prolactin: Distribution, Regulation, Functions, and Clinical Aspects*
1996
The effect of osteoarthritis definition on prevalence and incidence estimates: a systematic review
2011 Standout
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part I
2007 Standout
The use of methotrexate in childhood rheumatic diseases
1998
Hospitalizations for coronary artery disease among patients with systemic lupus erythematosus
2003
Therapy Insight: systemic lupus erythematosus as a risk factor for cardiovascular disease
2005
Crohn's disease clinical course and severity in obese patients
2002
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part II
2007 Standout
Polymorphism of the β3-adrenergic receptor and lipid profile in patients with rheumatoid arthritis and systemic lupus erythematosus treated with chloroquine
2003
Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial
2001 Standout
Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies
2008
Cerebral Atrophy Related to Corticotherapy in Systemic Lupus Erythematosus (SLE)
2001
Incidence and risk factors of thromboembolism in systemic lupus erythematosus: A comparison of three ethnic groups
2005
ASH evidence-based guidelines: should asymptomatic patients with antiphospholipid antibodies receive primary prophylaxis to prevent thrombosis?
2009
Adipocytokines: mediators linking adipose tissue, inflammation and immunity
2006 Standout
Protective effect of hydroxychloroquine in systemic lupus erythematosus. Prospective long-term study of an Israeli cohort{
2002
The Complex Role of Estrogens in Inflammation
2007 Standout
Sex hormones in the pathogenesis of systemic lupus erythematosus
2001
Prolactin (PRL) and Its Receptor: Actions, Signal Transduction Pathways and Phenotypes Observed in PRL Receptor Knockout Mice
1998 Standout
V Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose
2013 Standout
Review on Effectiveness of Primary Prophylaxis in aPLs with and without Risk Factors for Thrombosis: Efficacy and Safety
2014
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Age-related differences in glucocorticoid receptor mRNA levels in the human brain
2006
National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification
2003 Standout
Atherosclerotic plaque in carotid arteries in systemic lupus erythematosus: frequency and associated risk factors
2005
Treatment of Periodontitis and Endothelial Function
2007 Standout
Works of Urowitz Mb being referenced
Detection and modification of risk factors for coronary artery disease in patients with systemic lupus erythematosus: a quality improvement study.
1998
Premature coronary artery disease in systemic lupus erythematosus in the absence of corticosteroid use.
2000
Cranial computerized tomography in systemic lupus erythematosus.
1983
Prolactin in systemic lupus erythematosus.
1994
Methotrexate in systemic lupus erythematosus.
1994
Contribution of traditional risk factors to coronary artery disease in patients with systemic lupus erythematosus.
1999
Systemic lupus erythematosus in a patient with C4 deficiency.
1982